|
⚲
|
| Keyboard |
| Hagopian Henry III
✚
|
|
|---|---|
| CIK # | 0001821822 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001821822] | |
| 4 | [0001821822] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Annovis Bio Inc | |
| Hagopian Henry III | |
| Organogenesis Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Annovis Bio Inc ANVS
Common Stock
|
2023-11-20 | Grant | 824 | $6.07 | 5,002 |
|
Annovis Bio Inc ANVS
Common Stock
|
2023-04-07 | Grant | 1,000 | $12.61 | 12,610 |
|
Annovis Bio Inc ANVS
Stock Option (right to buy) · derivative
|
2023-01-18 | Grant | 7,672 | $0.00 | |
|
Annovis Bio Inc ANVS
Stock Option (right to buy) · derivative
|
2022-08-29 | Grant | 120,000 | $0.00 | |
|
Organogenesis Holdings Inc ORGO
Class A Common Stock
|
2021-01-13 | Grant | 10,700 | $0.00 | |
|
Organogenesis Holdings Inc ORGO
Stock Option (Right to Buy) · derivative
|
2021-01-13 | Grant | 64,198 | $0.00 | |
|
Organogenesis Holdings Inc ORGO
Stock Option (Right to Buy) · derivative
|
2020-08-21 | Grant | 15,000 | $0.00 |